On November 30, 2023, BrightPath Biotherapeutics Co., Ltd. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55 JPY | 0.00% |
|
-9.84% | -36.78% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
199 AUD | +1.29% | +3.97% | 47.75B | ||
55 JPY | 0.00% | -9.84% | 24.59M | ||
1st Jan change | Capi. | |
---|---|---|
-36.78% | 24.59M | |
+34.53% | 51.51B | |
-6.54% | 39.03B | |
+34.92% | 38.91B | |
-12.11% | 26.68B | |
+13.62% | 26.13B | |
-13.05% | 19.91B | |
+43.80% | 13.71B | |
+31.74% | 12.38B | |
-4.16% | 11.74B |
- Stock Market
- Equities
- 4594 Stock
- News BrightPath Biotherapeutics Co., Ltd.
- BrightPath Biotherapeutics Co., Ltd. announced that it has received ¥5.1678 million in funding from Macquarie Group Limited